Section 35CCC of the Income Tax Act: An Overview
CA Vishal Agarwal
CA Vishal Agarwal is a highly skilled and dedicated Chartered Accountant with extensive expertise in Goods and Services Tax (GST). With years of experience in the field, he has established himself as a trusted advisor to businesses and individuals across multiple locations in Bihar. His deep understanding of GST regulations, compliance, and advisory services has helped numerous clients navigate the complexities of taxation with ease and confidence.
Section 35CCC of the Income Tax Act provides a tax deduction to assessees undertaking approved agricultural extension projects in India. This deduction is available to companies engaged in biotechnology, pharmaceuticals, or scientific research. The deduction is available for expenditure incurred on research and development activities approved by the Department of Scientific and Industrial Research (DSIR).
Who is Eligible for Tax Benefits under Section 35CCC?
As mentioned earlier, the tax benefits under Section 35CCC are available to companies engaged in biotechnology, pharmaceuticals, or scientific research. The following are the eligibility criteria to claim the tax benefits:
- The company should have a valid DSIR registration.
- The company should have incurred expenses on scientific research and development activities approved by DSIR.
- The company must furnish the audit report along with its tax return, verifying the expenditure incurred on scientific research and development activities.
What are the tax benefits under Section 35CCC?
Companies that incur expenses on scientific research and development activities approved by DSIR can claim a tax deduction of 150% of the expenditure incurred. This means that if a company incurs an expenditure of ₹100 on approved research and development activities, it may claim a tax deduction of ₹150. The deduction can be claimed for expenses incurred on or after 1st April 2017.
It is important to note that the tax deduction under Section 35CCC is over and above the tax deduction available under Section 80IA. The tax deduction under Section 80IA is available to companies engaged in infrastructure development projects.
What are the expenses that can be claimed under Section 35CCC?
The following are the expenses that can be claimed under Section 35CCC:
- Expenditure on scientific research and development activities approved by DSIR.
- Expenditure on the acquisition of technology from a foreign company, provided the technology is not available in India.
- Expenditure on the transfer of technology from an Indian company to a foreign entity, provided that such technology is not otherwise available in India.
- Any other expenditure incurred on scientific research and development activities approved by DSIR.
It is important to note that the expenses incurred on land and buildings cannot be claimed under Section 35CCC.
How to claim tax benefits under Section 35CCC?
To claim tax benefits under Section 35CCC, the company should follow the steps below:
- Obtain a valid DSIR registration.
- Incur expenses on scientific research and development activities approved by DSIR.
- Obtain an audit report verifying the expenses incurred on scientific research and development activities.
- File the tax return along with the audit report.
- Claim a tax deduction of 150 percent of the expenditure incurred on approved scientific research and development activities in the tax return.
Conditions for Claiming Deduction
- Project Purpose: The project must be undertaken for the training, education, and guidance of farmers with the objective of improving their agricultural operations.
- Government Approval: The agricultural extension project must have prior approval from the Ministry of Agriculture and be notified by the Central Board of Direct Taxes (CBDT).
- Eligible Assessee: The deduction can be claimed by companies, firms, or individuals engaged in business or a profession that incur such expenditure.
- Eligible Expenditure: The deduction applies to actual expenditure incurred, excluding the cost of any land or building.
- Minimum Expenditure Threshold (previously): The expected expenditure for the project was required to exceed INR 25 lakhs for approval.
- No Double Deduction: An assessee cannot claim a deduction for the same expenditure under any other provision of the Income Tax Act for any assessment year.
- No Direct Benefit: The assessee should not receive any direct or indirect benefit from the project other than the tax deduction itself.
Compliance and Documentation
To successfully claim the deduction, the assessee must also comply with prescribed conditions and maintain proper documentation.
- Separate Accounts:Maintain separate books of accounts specifically for the agricultural extension project.
- Mandatory Audit:The accounts must be audited by a practicing Chartered Accountant, and an audit report (in Form 3CP) must be furnished.
- Annual Submission:Submit an audited statement of accounts and a certificate from the Ministry of Agriculture regarding the genuineness of the activities to the Commissioner/Director of Income-tax every year.
- Filing Application for Approval:The assessee must have made an application in Form 3C-O to the Member (IT), CBDT, before undertaking the project.
Conclusion
Section 35CCC of the Income Tax Act provides tax benefits to companies engaged in the business of biotechnology, pharmaceuticals, and scientific research. The tax deduction of 150% of the expenditure incurred on scientific research and development activities approved by DSIR is an incentive for businesses to invest in research and development. The government’s objective in introducing this provision is to encourage growth in India’s research and development sector, ultimately fostering technological advancement and economic growth.
For any clarifications or queries, please feel free to reach out to us at admin@fintracadvisors.com
Disclaimer
The content published on this blog is for informational purposes only. The opinions expressed here are solely those of the respective authors and do not necessarily reflect the views of Fintrac Advisors. No warranties are made regarding this information’s completeness, reliability, or accuracy. Any actions taken based on the information presented in this blog are solely at the reader’s risk, and we will not be liable for any losses or damages resulting from its use. It is recommended that professional expertise be sought for such matters. External links on this blog may direct users to third-party sites beyond our control. We do not take responsibility for their nature, content, or availability.


